Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Ivermectin
PapainLpro
Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022
Chloroquine phosphate
PapainLpro
Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021
Hydroxychloroquine sulfate
PapainLpro
Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021
Anacardic acid
PapainLpro
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Epigallocatechin Gallate
PapainLpro
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/08/2021
Salinomycin
PapainLpro
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/07/2021
Rutin
PapainLpro
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/02/2021
Cepharanthine
PapainLpro
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021
Emetine
PapainLpro
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021
Theaflavin gallate
PapainLpro
Potential treatment - theoretical effect Natural product Antiviral Mar/10/2021
Procyanidin B2
PapainLpro
Potential treatment - theoretical effect Natural product Antiviral Mar/10/2021
Theaflavin 3,3'-digallate
PapainLpro
Potential treatment - theoretical effect Natural product Antiviral Mar/10/2021
Hypericin
PapainLpro
Potential treatment - theoretical effect Natural product Antiviral Mar/08/2021
Boceprevir
PapainLpro
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021
Ginkgolic acid
PapainLpro
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/28/2021
Masoprocol
PapainLpro
Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021
Dobutamine
PapainLpro
Potential treatment - theoretical effect Used to treat other disease Antiviral Feb/24/2021
GRL0617
PapainLpro
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/20/2021
2-Bromo-3-fluoro-N-[(1-methyl-1H-indol-3-yl)sulfonyl]benzamide
PapainLpro
Potential treatment - theoretical effect Experimental Antiviral Feb/20/2021
Amentoflavone
PapainLpro
Potential treatment - theoretical effect Natural product Antiviral Feb/16/2021